{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:23:09Z","timestamp":1785417789526,"version":"3.56.0"},"reference-count":29,"publisher":"Scientific Scholar","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ruralneuropractice.com"],"crossmark-restriction":true},"short-container-title":["JNRP"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective<\/jats:bold>\u2003The objectives of this study are (1) to describe the non-motor profile, the motor disability progression, and survival analysis of atypical parkinsonism in a tertiary care hospital of eastern India and (2) to elucidate the neurocircuitry and the putative substrates responsible for non-motor manifestations.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold>\u2003In this prospective observational study, patients were diagnosed based on Consensus Criteria for Progressive Supranuclear Palsy (PSP), The Fourth Consensus Report of the Dementia with Lewy Body (DLBD) Consortium 2017, The Autonomic Neuroscience 2018 Criteria for Multiple System Atrophy (MSA), and Armstrong 2013 Criteria for Corticobasal Degeneration (CBD). Disease severity was assessed at baseline and 6 months of follow-up using the Unified Parkinson's Disease Rating Scales (UPDRS). For PSP and MSA, the PSP-Clinical Deficits Scale (PSP-CDS) and the Unified MSA Rating Scale (UMSARS), respectively, were used. Cox regression analysis and the hazard ratio were calculated.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold>\u2003Out of 27 patients, the diagnosis was probable PSP in 12, probable MSA in 7, probable CBD in 5, and probable DLBD in 3. Non-motor symptoms were highly prevalent across all subtypes. Motor disability progression as assessed by UPDRS parts 2 and 3 showed significant deterioration over 6-month follow-up across all groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Disease progression assessed by PSP-CDS and UMSARS over 6 months was significant (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). One PSP and two MSA patients died during a 6-month follow-up period. The hazard ratio in MSA was 3.5 (95% confidence interval: 0.31\u20130.38) with<jats:italic>p<\/jats:italic>\u2009=\u20090.306.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold>\u2003Atypical parkinsonian disorders are rare, and usually more severe than idiopathic parkinsonism. As no definitive treatment is available, symptomatic management involving a multidisciplinary team approach must be prioritized.<\/jats:p>","DOI":"10.1055\/s-0042-1744120","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T22:42:56Z","timestamp":1649371376000},"page":"276-282","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Non-motor Symptoms, Disability Progression, and Survival Analysis of Atypical Parkinsonism: Case Series from Eastern India and Brief Review of Literature"],"prefix":"10.25259","volume":"13","author":[{"given":"Tapas","family":"Pani","sequence":"first","affiliation":[{"name":"Department of Neurology, SCB Medical College and Hospital, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyadarshan","family":"Nayak","sequence":"additional","affiliation":[{"name":"Department of Neurology, SCB Medical College and Hospital, Cuttack, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"issue":"1","key":"10.1055\/s-0042-1744120\/ref-1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00415-009-5255-7","article-title":"Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study","volume":"257","author":"Colosimo","year":"2010","journal-title":"J Neurol"},{"issue":"1","key":"10.1055\/s-0042-1744120\/ref-2","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1038\/s41598-017-12457-6","article-title":"Separate neural representations of depression, anxiety and apathy in Parkinson's disease","volume":"7","author":"Dan","year":"2017","journal-title":"Sci Rep"},{"issue":"14","key":"10.1055\/s-0042-1744120\/ref-3","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.26048","article-title":"Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement","volume":"29","author":"Espay","year":"2014","journal-title":"Mov Disord"},{"issue":"5","key":"10.1055\/s-0042-1744120\/ref-4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1474-4422(15)00019-8","article-title":"Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment","volume":"14","author":"Pagonabarraga","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1055\/s-0042-1744120\/ref-5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-510X(00)00411-1","article-title":"Fatigue and basal ganglia","volume":"179","author":"Chaudhuri","year":"2000","journal-title":"J Neurol Sci"},{"issue":"9","key":"10.1055\/s-0042-1744120\/ref-6","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00415-018-9049-7","article-title":"Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis","volume":"266","author":"Rana","year":"2019","journal-title":"J Neurol"},{"issue":"9","key":"10.1055\/s-0042-1744120\/ref-7","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1007\/s00415-020-09881-6","article-title":"An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention","volume":"267","author":"Chelban","year":"2020","journal-title":"J Neurol"},{"issue":"12","key":"10.1055\/s-0042-1744120\/ref-8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/WNL.0000000000003751","article-title":"Nucleus of the solitary tract, medullary reflexes, and clinical implications","volume":"88","author":"Cutsforth-Gregory","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1055\/s-0042-1744120\/ref-9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/jnnp-2020-325546","article-title":"Sleep disturbance in movement disorders: insights, treatments and challenges","volume":"92","author":"Bailey","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1055\/s-0042-1744120\/ref-10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-804074-4.00001-7","article-title":"Anatomy and physiology of normal sleep","author":"Schneider","year":"2017"},{"issue":"5","key":"10.1055\/s-0042-1744120\/ref-11","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/nau.23496","article-title":"Neurogenic bladder in progressive supranuclear palsy: a comparison with Parkinson's disease and multiple system atrophy","volume":"37","author":"Kim","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1055\/s-0042-1744120\/ref-12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fneur.2019.00621","article-title":"Severe constipation in Parkinson's disease and in parkinsonisms: prevalence and affecting factors","volume":"10","author":"Frazzitta","year":"2019","journal-title":"Front Neurol"},{"key":"10.1055\/s-0042-1744120\/ref-13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.parkreldis.2020.06.018","article-title":"Life expectancy of parkinsonism patients in the general population","volume":"77","author":"Dommershuijsen","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.1055\/s-0042-1744120\/ref-14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"10.1055\/s-0042-1744120\/ref-15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1055\/s-0042-1744120\/ref-16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2017.10.007","article-title":"Diagnosis of multiple system atrophy","volume":"211","author":"Palma","year":"2018","journal-title":"Auton Neurosci"},{"issue":"5","key":"10.1055\/s-0042-1744120\/ref-17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1055\/s-0042-1744120\/ref-18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/mds.27964","article-title":"The Progressive Supranuclear Palsy Clinical Deficits Scale","volume":"35","author":"Piot","year":"2020","journal-title":"Mov Disord"},{"issue":"12","key":"10.1055\/s-0042-1744120\/ref-19","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov Disord"},{"issue":"1","key":"10.1055\/s-0042-1744120\/ref-20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/aian.AIAN_611_20","article-title":"Subtypes of PSP and prognosis: a retrospective analysis","volume":"24","author":"Mahale","year":"2021","journal-title":"Ann Indian Acad Neurol"},{"issue":"3","key":"10.1055\/s-0042-1744120\/ref-21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","article-title":"The natural history of multiple system atrophy: a prospective European cohort study","volume":"12","author":"Wenning","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1055\/s-0042-1744120\/ref-22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jnnp.2006.103929","article-title":"Causes of death in multiple system atrophy","volume":"78","author":"Papapetropoulos","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1055\/s-0042-1744120\/ref-23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1469-7793.2001.t01-1-00237.x","article-title":"Pathogenesis of laryngeal narrowing in patients with multiple system atrophy","volume":"536","author":"Isono","year":"2001","journal-title":"J Physiol"},{"key":"10.1055\/s-0042-1744120\/ref-24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2019.11.025","article-title":"Vocal cord electromyographic correlates of stridor in multiple system atrophy phenotypes","volume":"70","author":"Todisco","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1055\/s-0042-1744120\/ref-25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.20021","article-title":"Involvement of medullary serotonergic groups in multiple system atrophy","volume":"55","author":"Benarroch","year":"2004","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1055\/s-0042-1744120\/ref-26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mdc3.12879","article-title":"Falls in progressive supranuclear palsy","volume":"7","author":"Brown","year":"2019","journal-title":"Mov Disord Clin Pract (Hoboken)"},{"issue":"8","key":"10.1055\/s-0042-1744120\/ref-27","doi-asserted-by":"crossref","first-page":"e0135823","DOI":"10.1371\/journal.pone.0135823","article-title":"Impact of aspiration pneumonia on the clinical course of progressive supranuclear palsy: a retrospective cohort study","volume":"10","author":"Tomita","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1055\/s-0042-1744120\/ref-28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1152\/physrev.2001.81.2.929","article-title":"Brain stem control of swallowing: neuronal network and cellular mechanisms","volume":"81","author":"Jean","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1055\/s-0042-1744120\/ref-29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4274\/tnd.2020.45467","article-title":"Update on therapeutic strategies for atypical parkinsonian syndromes","volume":"26","author":"Maghbooli","year":"2020","journal-title":"Turkish J Neurol"}],"container-title":["Journal of Neurosciences in Rural Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ruralneuropractice.com\/the-non-motor-symptoms-disability-progression-and-survival-analysis-of-atypical-parkinsonism-case-series-from-eastern-india-and-brief-review-of-literature\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ruralneuropractice.com\/the-non-motor-symptoms-disability-progression-and-survival-analysis-of-atypical-parkinsonism-case-series-from-eastern-india-and-brief-review-of-literature\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T19:56:47Z","timestamp":1700423807000},"score":1,"resource":{"primary":{"URL":"https:\/\/ruralneuropractice.com\/the-non-motor-symptoms-disability-progression-and-survival-analysis-of-atypical-parkinsonism-case-series-from-eastern-india-and-brief-review-of-literature\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":29,"alternative-id":["10.1055\/s-0042-1744120"],"URL":"https:\/\/doi.org\/10.1055\/s-0042-1744120","relation":{},"ISSN":["0976-3155","0976-3147"],"issn-type":[{"value":"0976-3155","type":"electronic"},{"value":"0976-3147","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"article-number":"276"}}